xMAP Webinars Archives - Luminex Corporation
Customer Center
Login | Register

Archives

Webinar: xMAP® Technology Drives Development of Prostate Cancer Detection Assay

August 8th, 2018 / Hilary Graham

Better test accuracy reduces the need for invasive biopsy procedures For a startup company striving to deliver diagnostics that improve health care for patients who may have prostate cancer, Luminex’s xMAP® Technology is a critical tool in the assay development process. According to a webinar presentation from Ramy Huber, a research associate at ProteoMediX, the assay

Continue reading »

Webinar Wednesday: For Tracking Anti-Apoptosis Proteins, Scientists Turn to Multiplexing

July 25th, 2018 / Hilary Graham

AbbVie team uses Luminex-based immunoassay for drug discovery applications According to Dr. Lloyd Lam, a senior scientist at AbbVie, measuring the expression of anti-apoptotic proteins such as BCL-2 is an easier and more cost-effective task when done with a multiplex immunoassay. Lam spoke in a Nature webinar entitled “Multiplex assays of the anti-apoptotic BCL-2 family,”

Continue reading »

How to Multiplex Analysis of Autoimmune Biomarkers

July 11th, 2018 / Hilary Graham

At Protagen, scientists enlist xMAP® Technology to characterize autoantibodies Multiplex analysis of autoantibodies is an effective way to understand autoimmune disease, discover important biomarkers, and stratify patients into subgroups, according to Hans-Dieter Zucht, Head of Technology at Protagen. The company uses a biomarker discovery platform for autoimmune disease and immuno-oncology applications. In a presentation about autoantibody

Continue reading »

Webinar Wednesday: Immunoassay Multiplexing Master Class

June 20th, 2018 / Hilary Graham

From assay development to workflow protocols, how to run a multiplex immunoassay If you could run in 3 hours an immunoassay workflow that would normally take more than 60 hours, that wouldn’t be a tough decision, would it? A step-by-step tutorial webinar from Brett Houser at Bio-Rad shows you exactly how to make that transition.

Continue reading »

xMAP® Assays Reveal More About Immune Response than Traditional Vaccine ELISAs

May 30th, 2018 / Hilary Graham

Serotype-specific assays pinpoint threshold values missed by standard tests If you use ELISAs to test immunological responses, Siân Faustini from the University of Birmingham has this advice: “Serotype-specific assays are the way to go.” In her 20-minute webinar presentation from xMAP® Connect 2017, “Exploring immunological assays to assess responses to pneumococcal polysaccharide and conjugate vaccines

Continue reading »

Webinar Wednesday: Reduce False Positive Results in HLA Testing with Immucor Assay

May 2nd, 2018 / Hilary Graham

xMAP® bead-based multiplexing technology helps eliminate denatured antigens Scientists who perform HLA antibody tests are all too familiar with the challenge of false positives: many assays react with denatured antigens to generate a positive result even when the intact antigen was not detected. Various approaches have been used to overcome this, but a new method

Continue reading »

Webinar Wednesday: Overcome Biomarker Multiplexing Challenges in Drug Development

April 18th, 2018 / Hilary Graham

Paul Rhyne from BDS Shares Recommended Multiplexing Techniques Paul Rhyne, PhD, Chief Scientific Officer at Biologic Development Services (BDS), shares insights from a review article co-authored with 11 colleagues from pharmaceutical companies, clinical research organizations (CRO), and government agencies over two years titled: Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in

Continue reading »

Webinar Wednesday: James Lederer from Harvard Medical School

April 4th, 2018 / Hilary Graham

Use of xMAP® Technology to Measure Complex Immune Response to Infection in Mice For our fifth Webinar Wednesday blog, we’re featuring a talk from James Lederer, PhD, Associate Professor of Surgery at Harvard Medical School. Lederer is an xMAP® expert, having developed approximately 200 multiplex immunoassays to study the effects of trauma on the immune

Continue reading »

Webinar Wednesday: Mariano Severgnini from Dana-Farber Cancer Institute

March 21st, 2018 / Hilary Graham

Soluble Biomarker Detection in Cancer Patients Treated with Immunotherapies using xMAP® Technology For our fourth Webinar Wednesday blog, we’re featuring a talk from Mariano Severgnini, who is the lead scientist at the Immune Assessment Lab (IAL) in the Center for Immuno-Oncology (CIO) at Dana-Farber Cancer Institute. The IAL serves as the focal point for immunotherapy

Continue reading »

Webinar Wednesday: John Davis from the Broad Institute

March 7th, 2018 / Hilary Graham

Multiplexed Gene Expression Profiling with L1000 For our third Webinar Wednesday blog, we’re featuring a talk from John Davis, who is the Profiling Production Lead on the Connectivity Map (CMap) team at the Broad Institute. The CMap links genes, disease states, and cellular perturbations in an easy to use database designed for biologists, chemists, and

Continue reading »